Abstract | BACKGROUND: OBJECTIVE: To verify the association between MTHFR C677T and A1298C polymorphisms and Alzheimer's disease. METHOD: This work was conducted as a case-control study. Cases consisted of thirty-eight patients and 100 individuals without dementia constituted the control group. Genotyping of MTHFR polymorphisms was performed on patients and controls. RESULT: Genetic analyses did not indicate a significant association between the MTHFR C677T mutation and AD (C/T: 63.15% versus 39%, p=0.087). However, the genotype prevalence of the missense variant MTHFR A1298C was significantly different between patients and controls (A/C: 55% versus 7%, p<10(-3)). Our data suggest an association between the MTHFR A1298C mutation and AD; however, the MTHFR C677T mutation did not contribute to susceptibility for AD. CONCLUSION:
|
Authors | Leila Mansouri, Najiba Fekih-Mrissa, Sarra Klai, Malek Mansour, Nasreddine Gritli, Ridha Mrissa |
Journal | Clinical neurology and neurosurgery
(Clin Neurol Neurosurg)
Vol. 115
Issue 9
Pg. 1693-6
(Sep 2013)
ISSN: 1872-6968 [Electronic] Netherlands |
PMID | 23659764
(Publication Type: Journal Article)
|
Copyright | Copyright © 2013 Elsevier B.V. All rights reserved. |
Chemical References |
- Homocysteine
- MTHFR protein, human
- Methylenetetrahydrofolate Reductase (NADPH2)
|
Topics |
- Aged
- Aged, 80 and over
- Alleles
- Alzheimer Disease
(epidemiology, genetics)
- Female
- Gene Frequency
- Genetic Predisposition to Disease
- Genotype
- Homocysteine
(blood)
- Humans
- Male
- Methylenetetrahydrofolate Reductase (NADPH2)
(genetics)
- Middle Aged
- Mutation
(genetics, physiology)
- Mutation, Missense
(genetics)
- Polymorphism, Genetic
(genetics)
- Risk Factors
|